Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00120094
Other study ID # ISS2
Secondary ID
Status Terminated
Phase Phase 4
First received June 30, 2005
Last updated April 10, 2006
Start date June 2002
Est. completion date June 2005

Study information

Verified date July 2005
Source Arcispedale Santa Maria Nuova-IRCCS
Contact n/a
Is FDA regulated No
Health authority United Kingdom: National Health Service
Study type Observational

Clinical Trial Summary

This is a multi-center, prospective, observational study enrolling 400 patients with suspected or certain neurally-mediated syncope, who undergo carotid sinus massage, tilt testing and Implantable Loop Recorder (ILR)implantation. In its second phase, which starts after the first ILR-documented syncope, the study will register the patient outcome after administration of ILR-guided therapy, which is left to the discretion of the physicians. The main objective is to verify the value of ILR in assessing the mechanism of syncope and the efficacy of the ILR-guided therapy after syncope recurrence.


Description:

Study purpose was to verify the value of an Implanted Loop Recorder (ILR) in assessing the mechanism of syncope and the efficacy of ILR-guided therapy after documentation of syncope recurrence in patients with suspected or certain neurally-mediated syncope at initial evaluation.

Multi-center, prospective, observational study enrolling 400 patients with suspected or certain neurally-mediated syncope, who undergo carotid sinus massage, tilt testing and ILR implantation. In its second phase, which starts after the first ILR-documented syncope, the study will register the patient outcome after administration of ILR-guided therapy, which is left to the discretion of the physicians.

Main objective: To verify the value of ILR in assessing the mechanism of syncope and the efficacy of the ILR-guided therapy after syncope recurrence.

Secondary objectives:

1. To define the exact mechanism of syncope in patients with suspected or certain neurally-mediated syncope based on the initial evaluation;

2. To prospectively evaluate the correlation between tilt-induced syncope, ATP-induced asystolic response and/or carotid sinus hypersensitivity and ILR-documented spontaneous syncope associated with bradycardia and/or asystole;

3. To assess the relationship between asymptomatic and symptomatic asystoles;

4. To assess the effectiveness of pacing therapy for preventing syncope recurrence in patients implanted with a pacemaker after an ILR-documented syncope associated with asystole/bradycardia.

Inclusion criteria:

- Suspected or certain neurally-mediated syncope, based on the Guidelines of the ESC TF on Syncope.

- 3 syncope episodes in the last 2 years.

- Severe clinical presentation of syncope requiring treatment initiation in the judgement of the investigator.

- Age >30 years.

- Patients have undergone carotid sinus massage, and ILR implantation.

Exclusion criteria:

- ILR not implanted for any reason; in this case, the patients are still followed in the ILR-not implanted group.

- Carotid sinus syndrome.

- Suspected or certain cardiac syncope.

- Symptomatic orthostatic hypotension diagnosed by standing blood pressure measurement.

- Loss of consciousness different from syncope (e.g. epilepsy, psychiatric, metabolic, drop-attack, TIA, intoxication, cataplexy).

- Steal syndrome.

- Psychologically or physically (due to any other illness) unfit for participation in the study according to the opinion of the investigator.

- Patient compliance doubtful.

- Patients who are geographically or otherwise inaccessible for follow-up.

- Patient unwilling or unable to give informed consent;

- Pregnancy.

- Life expectancy < 1 year due to non-cardiac cause.

Primary endpoints: Phase 1: first ECG-documented syncope Phase 2: first syncope recurrence after implementation of ILR-guided therapy

Secondary endpoints: Phase 1:

- Asymptomatic ILR-documented arrhythmia

- ILR-documented pre-syncope/s

Phase 2:

- Total number of syncopal recurrences

- Pre-syncope recurrence

Study duration: ISSUE 2 will enroll a minimum of 400 patients during an anticipated period of 3 years. As the study will continue for a period of 6 months after the enrollment of the last patient, total study duration will be approximately 4 years.


Recruitment information / eligibility

Status Terminated
Enrollment 400
Est. completion date June 2005
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 30 Years and older
Eligibility Inclusion Criteria:

- Suspected or certain neurally-mediated syncope, based on the Guidelines of the ESC TF on Syncope.

- 3 syncope episodes in the last 2 years.

- Severe clinical presentation of syncope requiring treatment initiation in the judgement of the investigator.

- Age >30 years.

- Patients have undergone carotid sinus massage, and ILR implantation.

Exclusion Criteria:

- ILR not implanted for any reason; in this case, the patients are still followed in the ILR-not implanted group.

- Carotid sinus syndrome.

- Suspected or certain cardiac syncope.

- Symptomatic orthostatic hypotension diagnosed by standing blood pressure measurement.

- Loss of consciousness different from syncope (e.g. epilepsy, psychiatric, metabolic, drop-attack, TIA, intoxication, cataplexy).

- Steal syndrome.

- Psychologically or physically (due to any other illness) unfit for participation in the study according to the opinion of the investigator.

- Patient compliance doubtful.

- Patients who are geographically or otherwise inaccessible for follow-up.

- Patient unwilling or unable to give informed consent;

- Pregnancy.

- Life expectancy < 1 year due to non-cardiac cause

Study Design

Observational Model: Defined Population, Primary Purpose: Screening, Time Perspective: Longitudinal


Related Conditions & MeSH terms


Locations

Country Name City State
Italy Department of Cardiology, Arrhythmologic Centre Lavagna Genova
Italy Arcispedale S Maria Nuova Reggio Emilia
United Kingdom Royal Brompton Hospital London SW3 6NP

Sponsors (2)

Lead Sponsor Collaborator
Arcispedale Santa Maria Nuova-IRCCS Medtronic

Countries where clinical trial is conducted

Italy,  United Kingdom, 

References & Publications (2)

Brignole M, Sutton R, Menozzi C, Garcia-Civera R, Moya A, Wieling W, Andresen D, Benditt DG, Vardas P; International Study on Syncope of Uncertain Etiology 2 (ISSUE 2) Group. Early application of an implantable loop recorder allows effective specific ther — View Citation

Steering Committee of the ISSUE 2 study. International Study on Syncope of Uncertain Etiology 2: the management of patients with suspected or certain neurally mediated syncope after the initial evaluation rationale and study design. Europace. 2003 Jul;5(3):317-21. Review. — View Citation

See also
  Status Clinical Trial Phase
Completed NCT06038708 - Head-up Tilt Test in Patients With Reflex Syncope and Asystolic Response Who Received a Dual-chamber Pacemaker With the Closed Loop Stimulation (CLS) and Participated in the BIOSync Trial
Completed NCT00069693 - Evaluation of Chronic Orthostatic Intolerance N/A
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Completed NCT02565238 - BIO.MASTER.BioMonitor 2 Study N/A
Active, not recruiting NCT01965899 - Usability Study to Assess the Reveal LINQ Insertable Cardiac Monitor System N/A
Completed NCT00746564 - Study of New Implantable Loop Recorder N/A
Completed NCT00359203 - ISSUE3: International Study on Syncope of Uncertain Etiology 3 Phase 4
Recruiting NCT04972071 - SW-RCT Implementation of Canadian Syncope Risk Score Based Practice Recommendations N/A
Completed NCT04198220 - BIO|STREAM.ICM Obesity
Recruiting NCT04533425 - Practical Approaches to Care in Emergency Syncope
Completed NCT05571254 - The Management of Transient Loss of Consciousness and Suspected Syncope in European Emergency Departments
Recruiting NCT05621460 - The Effect of Water Carbonation on Orthostatic Tolerance N/A
Not yet recruiting NCT05957315 - Mobile Cardiac Outpatient Telemetry for Unexplained Syncope N/A
Recruiting NCT04615065 - Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
Completed NCT05729724 - Effect of Pharmacological Interventions on Systolic Blood Pressure Drops (SynABPM 2 Proof-of-concept)
Completed NCT05782712 - Rapid Measurement of Adenosine in Syncope Patients
Completed NCT03786640 - Abbott Brady 3T MRI PMCF
Recruiting NCT03803969 - ConfirmRxTM: Posture and Activity N/A
Recruiting NCT05575934 - Management of Transitory Loss of Consciousness and Syncopes in the Emergency Department
Recruiting NCT04075084 - Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)